Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?

Pier Giorgio Puzzovio; Ron Eliashar; Francesca Levi-Schaffer

doi:10.1016/j.jaci.2022.01.019

Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?

Pier Giorgio Puzzovio, Ron Eliashar, Francesca Levi-Schaffer^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

6 Scopus citations

Original language	English
Pages (from-to)	1582-1584
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology
Volume	149
Issue number	5
Early online date	8 Feb 2022
DOIs	https://doi.org/10.1016/j.jaci.2022.01.019
State	Published - May 2022

Bibliographical note

Funding Information:
This study was supported by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (grant no. 442/18 ), Israel Ministry of Science & Technology , and Emalie Gutterman Memorial Endowed Fund for COPD Related Research .

Keywords

Allergic effector unit
TSLP
airway hyperresponsiveness
allergic inflammation
asthma
eosinophils
mast cells
Cytokines
Humans
Antibodies, Monoclonal, Humanized/therapeutic use
Asthma/drug therapy
Leukocyte Count
Eosinophils

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaci.2022.01.019

Cite this

@article{b7e5e52706cf47ccaa479e087068defd,

title = "Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?",

keywords = "Allergic effector unit, TSLP, airway hyperresponsiveness, allergic inflammation, asthma, eosinophils, mast cells, Cytokines, Humans, Antibodies, Monoclonal, Humanized/therapeutic use, Asthma/drug therapy, Leukocyte Count, Eosinophils",

author = "Puzzovio, {Pier Giorgio} and Ron Eliashar and Francesca Levi-Schaffer",

note = "Funding Information: This study was supported by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (grant no. 442/18 ), Israel Ministry of Science & Technology , and Emalie Gutterman Memorial Endowed Fund for COPD Related Research . ",

year = "2022",

month = may,

doi = "10.1016/j.jaci.2022.01.019",

language = "אנגלית",

volume = "149",

pages = "1582--1584",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Tezepelumab administration in moderate-to-severe uncontrolled asthma

T2 - Is it all about eosinophils?

AU - Puzzovio, Pier Giorgio

AU - Eliashar, Ron

AU - Levi-Schaffer, Francesca

N1 - Funding Information: This study was supported by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (grant no. 442/18 ), Israel Ministry of Science & Technology , and Emalie Gutterman Memorial Endowed Fund for COPD Related Research .

PY - 2022/5

Y1 - 2022/5

KW - Allergic effector unit

KW - TSLP

KW - airway hyperresponsiveness

KW - allergic inflammation

KW - asthma

KW - eosinophils

KW - mast cells

KW - Cytokines

KW - Humans

KW - Antibodies, Monoclonal, Humanized/therapeutic use

KW - Asthma/drug therapy

KW - Leukocyte Count

KW - Eosinophils

UR - http://www.scopus.com/inward/record.url?scp=85124739725&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2022.01.019

DO - 10.1016/j.jaci.2022.01.019

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 35149043

AN - SCOPUS:85124739725

SN - 0091-6749

VL - 149

SP - 1582

EP - 1584

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -

Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Cite this